Abstract
Purpose: To evaluate the efficacy and safety of intravitreal bevacizumab (IVB) and adjunctive Strontium-90 (Sr) beta radiotherapy with trabeculectomy in the management of neovascular glaucoma (NVG). Methods: Thirty seven eyes with NVG were randomly selected and divided into two groups according to the treatment given Group 1: Trabeculectomy with Beta-irradiation (n=18 eyes). Group 2: Preoperative (IVB) followed after two weeks by trabeculectomy and Betairradiation (n=19 eyes). Intraocular pressure (IOP), and regression of rubiosis iridis (NVI) are the used outcome measures. Results: By 6 months postoperatively, the mean IOP levels decreased from 38.6mmHg pre-operatively to 11.3mmHg on the first postoperative week and 16.2 at the end of follow up for all cases. No significant difference between both groups as regard of success, while group 2 (IVB) showed more regression of NVI and less incidence of complications. Conclusion: Preoperative IVB combined with filtration surgery and adjuvant Strontium-90 (Sr) beta radiotherapy is a safe and effective method of controlling intraocular pressure in NVG. Original Article Research Sabour et al.; OR, Article no. OR.2014.005 213
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
